CTS Corp's Q3 Net Income Dips 24% Despite Sales Growth

TL;DR

**CTS Corp's Q3 profit drop despite higher sales is a red flag; watch those rising expenses.**

AI Summary

CTS Corp reported net sales of $142.97 million for the three months ended September 30, 2025, an increase of 8% from $132.38 million in the same period of 2024. However, net earnings decreased by 24.3% to $13.69 million in Q3 2025 from $18.08 million in Q3 2024. Diluted EPS also fell to $0.46 from $0.59 year-over-year. For the nine months ended September 30, 2025, net sales rose to $404.05 million from $388.30 million, a 4.1% increase, while net earnings grew by 3.8% to $45.58 million from $43.91 million. The company corrected immaterial prior period errors related to the SyQwest, LLC acquisition and foreign currency impact on long-term debt payments, which reduced previously reported 2024 net earnings by $2.64 million. Cash and cash equivalents increased to $110.30 million as of September 30, 2025, from $94.33 million at December 31, 2024, driven by $72.89 million in operating cash flow. Long-term debt saw significant activity with $878.10 million in payments and $876.50 million in borrowings for the nine months ended September 30, 2025.

Why It Matters

CTS Corp's mixed Q3 results, with rising sales but falling net income, signal potential margin pressures or increased operational costs that investors should scrutinize. The significant increase in selling, general, and administrative expenses by $4.71 million and research and development expenses by $1.87 million in Q3 2025 compared to Q3 2024 could be impacting profitability. For employees, continued investment in R&D might suggest future growth areas, but the dip in net earnings could raise concerns about overall company performance. Customers might benefit from new product development stemming from increased R&D. In a competitive market, maintaining profitability while growing sales is crucial for long-term investor confidence and market positioning.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant decline in net earnings for the three months ended September 30, 2025, by 24.3% to $13.69 million, despite an 8% increase in net sales. This indicates potential margin compression or rising operational costs, specifically a $4.71 million increase in selling, general and administrative expenses and a $1.87 million increase in research and development expenses year-over-year for the quarter, which could impact future profitability.

Analyst Insight

Investors should closely monitor CTS Corp's upcoming earnings calls for management's explanation of the Q3 net income decline and strategies to improve profitability. Evaluate the sustainability of sales growth against rising operating expenses. Consider if the increased R&D spending will translate into future revenue streams or if it's merely a drag on current earnings.

Financial Highlights

revenue

$142.97M

net Income

$13.69M

eps

$0.46

cash Position

$110.30M

revenue Growth

+8%

Key Numbers

• $142.97M — Net Sales (Q3 2025) (Increased 8% from $132.38M in Q3 2024)
• $13.69M — Net Earnings (Q3 2025) (Decreased 24.3% from $18.08M in Q3 2024)
• $0.46 — Diluted EPS (Q3 2025) (Decreased from $0.59 in Q3 2024)
• $404.05M — Net Sales (YTD 2025) (Increased 4.1% from $388.30M in YTD 2024)
• $45.58M — Net Earnings (YTD 2025) (Increased 3.8% from $43.91M in YTD 2024)
• $110.30M — Cash and Cash Equivalents (As of September 30, 2025, up from $94.33M at Dec 31, 2024)
• $72.89M — Net Cash Provided by Operating Activities (For nine months ended September 30, 2025)
• $27.22M — SG&A Expenses (Q3 2025) (Increased from $22.51M in Q3 2024)
• $6.90M — R&D Expenses (Q3 2025) (Increased from $5.03M in Q3 2024)
• $2.64M — Prior Period Error Correction (Reduction in previously reported 2024 net earnings)

Key Players & Entities

• CTS CORPORATION (company) — Registrant in the 10-Q filing
• SyQwest, LLC (company) — Company acquired, subject to prior period error correction
• SEC (regulator) — Securities and Exchange Commission
• $142,970 (dollar_amount) — Net sales for three months ended September 30, 2025
• $132,384 (dollar_amount) — Net sales for three months ended September 30, 2024
• $13,687 (dollar_amount) — Net earnings for three months ended September 30, 2025
• $18,084 (dollar_amount) — Net earnings for three months ended September 30, 2024
• $404,047 (dollar_amount) — Net sales for nine months ended September 30, 2025
• $45,581 (dollar_amount) — Net earnings for nine months ended September 30, 2025
• $2,642 (dollar_amount) — Correction to previously reported 2024 net earnings

FAQ

Risk Factors

• Supply Chain Disruptions [medium — market]: The company's operations are subject to risks associated with global supply chain disruptions, which can impact the availability and cost of raw materials and components. This could lead to production delays and affect the ability to meet customer demand, as seen in the broader electronics manufacturing sector.
• Environmental Regulations [medium — regulatory]: CTS Corp operates in industries subject to evolving environmental regulations. Compliance with these regulations, particularly concerning emissions and waste disposal, requires ongoing investment and can increase operating costs. Failure to comply could result in fines or operational restrictions.
• Dependence on Key Customers [medium — operational]: A significant portion of the company's revenue may be derived from a limited number of key customers. The loss of one or more of these customers, or a substantial reduction in their orders, could materially and adversely affect the company's financial results.
• Interest Rate Fluctuations [medium — financial]: The company's financial condition is exposed to fluctuations in interest rates, particularly given its significant long-term debt. Changes in interest rates can affect the cost of borrowing and the fair value of its debt instruments, as indicated by the $878.10 million in payments and $876.50 million in borrowings during the nine months ended September 30, 2025.
• Intellectual Property Disputes [low — legal]: The company's success depends on its ability to protect its intellectual property. Disputes or litigation related to patents, trademarks, or other intellectual property rights could be costly and divert management attention.
• Cybersecurity Threats [medium — operational]: As a technology-reliant company, CTS Corp is vulnerable to cybersecurity threats that could disrupt operations, compromise sensitive data, and damage its reputation. The increasing sophistication of cyberattacks poses a continuous risk.

Industry Context

CTS Corp operates within the highly competitive electronics components and systems market, serving diverse industries such as automotive, communications, and defense. Key trends include increasing demand for advanced materials, miniaturization, and higher performance specifications. The industry is characterized by rapid technological advancements and a need for continuous innovation to maintain market share.

Regulatory Implications

The company faces ongoing scrutiny regarding environmental compliance and product safety standards across its global operations. Adherence to evolving regulations, particularly in areas like emissions and material sourcing, is critical to avoid penalties and maintain operational continuity. The company's disclosures on risk factors suggest a proactive approach to managing these regulatory landscapes.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-09-30: End of Q3 2025 — Reported net sales of $142.97 million, an 8% increase year-over-year, but net earnings decreased by 24.3% to $13.69 million. Diluted EPS fell to $0.46 from $0.59.
• 2025-09-30: End of Nine Months 2025 — Net sales reached $404.05 million (up 4.1%), and net earnings grew 3.8% to $45.58 million. Operating cash flow was $72.89 million.
• 2025-09-30: Balance Sheet Date — Cash and cash equivalents stood at $110.30 million, an increase from $94.33 million at the end of 2024.
• 2024-12-31: End of Fiscal Year 2024 — Cash and cash equivalents were $94.33 million. Prior period errors related to SyQwest, LLC acquisition and foreign currency impact reduced 2024 net earnings by $2.64 million.

Glossary

Diluted EPS

Earnings Per Share (EPS) that accounts for all dilutive potential common shares outstanding, including convertible debt, options, and warrants. It represents the earnings attributable to each share of common stock on a fully diluted basis. (Indicates the profitability on a per-share basis, reflecting the impact of potential share dilution. A decrease from $0.59 to $0.46 in Q3 2025 signals reduced profitability per share.)

SyQwest, LLC acquisition

A business acquisition by CTS Corp. The filing mentions prior period errors related to this acquisition that required restatement. (The correction of immaterial errors related to this acquisition reduced previously reported 2024 net earnings by $2.64 million, impacting historical financial comparisons.)

Operating Cash Flow

The cash generated from a company's normal business operations. It is a key indicator of a company's ability to generate cash to maintain and grow its operations. (CTS Corp generated $72.89 million in operating cash flow for the nine months ended September 30, 2025, demonstrating strong cash generation from its core business activities.)

Prior Period Errors

Mistakes in previously issued financial statements that are corrected in the current period. These can relate to accounting principles, calculations, or disclosures. (The correction of immaterial prior period errors reduced 2024 net earnings by $2.64 million, highlighting the importance of accurate financial reporting and the impact of adjustments.)

Year-Over-Year Comparison

Compared to the prior year, CTS Corp reported an 8% increase in net sales for Q3 2025, reaching $142.97 million. However, this top-line growth was overshadowed by a significant 24.3% decrease in net earnings to $13.69 million and a drop in diluted EPS from $0.59 to $0.46. While year-to-date sales showed a modest 4.1% increase, the divergence in profit trends between Q3 and the year-to-date period warrants close examination. New risk factors related to supply chain and cybersecurity are also present.

Filing Documents

• cts-20250930.htm (10-Q) — 3817KB
• cts-ex31_a.htm (EX-31.(A)) — 17KB
• cts-ex31_b.htm (EX-31.(B)) — 17KB
• cts-ex32_a.htm (EX-32.(A)) — 12KB
• cts-ex32_b.htm (EX-32.(B)) — 12KB
• 0001193125-25-253188.txt ( ) — 17944KB
• cts-20250930.xsd (EX-101.SCH) — 1503KB
• cts-20250930_htm.xml (XML) — 4868KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Condensed Consolidated Statements of Earnings (Unaudited) For the Three and Nine Months Ended September 30, 2025 and September 30, 2024 3 Condensed Consolidated Statements of Comprehensive Earnings (Unaudited) For the Three and Nine Months Ended September 30, 2025 and September 30, 2024 4 Condensed Consolidated Balance Sheets (Unaudited) As of September 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Cash Flows (Unaudited) For the Nine Months Ended September 30, 2025 and September 30, 2024 6 Condensed Consolidated Statements of Shareholders' Equity (Unaudited) For the Three and Nine Months Ended September 30, 2025 and September 30, 2024 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 31 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 37 Item 4.

Controls and Procedures

Controls and Procedures 38

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 38 Item 1A.

Risk Factors

Risk Factors 38 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39 Item 5. Other Information 39 Item 6. Exhibits 40

SIGNATURES

SIGNATURES 41 2

- FINANCI AL INFORMATION

PART I - FINANCI AL INFORMATION

Finan cial Statements

Item 1. Finan cial Statements CTS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEM ENTS OF EARNINGS - UNAUDITED (In thousands, except per share amounts) Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2025 2024 2025 2024 Net sales $ 142,970 $ 132,384 $ 404,047 $ 388,296 Cost of goods sold 87,629 83,195 249,727 247,645 Gross margin 55,341 49,189 154,320 140,651 Selling, general and administrative expenses 27,222 22,509 73,922 66,100 Research and development expenses 6,901 5,031 19,416 17,718 Restructuring charges 280 773 1,028 3,657 Operating earnings 20,938 20,876 59,954 53,176 Other income (expense): Interest expense ( 1,110 ) ( 1,307 ) ( 3,398 ) ( 2,942 ) Interest income 535 973 1,603 3,800 Other income (expense), net ( 643 ) 1,306 665 ( 761 ) Total other income (expense), net ( 1,218 ) 972 ( 1,130 ) 97 Earnings before income taxes 19,720 21,848 58,824 53,273 Income tax expense 6,033 3,764 13,243 9,364 Net earnings $ 13,687 $ 18,084 $ 45,581 $ 43,909 Earnings per share: Basic $ 0.47 $ 0.60 $ 1.53 $ 1.44 Diluted $ 0.46 $ 0.59 $ 1.52 $ 1.43 Basic weighted – average common shares outstanding: 29,348 30,300 29,698 30,517 Effect of dilutive securities 279 236 281 230 Diluted weighted – average common shares outstanding: 29,627 30,536 29,979 30,747 Cash dividends declared per share $ 0.04 $ 0.04 $ 0.12 $ 0.12 See notes to unaudited condensed consolidated financial statements. 3 CTS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS UNAUDITED (In thousands) Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, 2025 2024 2025 2024